Valuation: Kuros Biosciences AG

Market Cap 780M 944M 846M 708M 1.34B 88.46B 1.38B 9.34B 3.72B 47.4B 3.54B 3.47B 150B P/E 2026 *
85.6x
P/E 2027 * 42x
Enterprise Value 774M 936M 839M 703M 1.33B 87.75B 1.37B 9.26B 3.69B 47.02B 3.51B 3.44B 149B EV / Sales 2026 *
4.55x
EV / Sales 2027 * 3.44x
Free-Float
65.78%
Yield 2026 *
-
Yield 2027 * -
1 day-2.78%
1 week-2.39%
Current month-5.14%
1 month+6.70%
3 months-15.09%
6 months-2.68%
Current year-28.75%
1 week 19.44
Extreme 19.44
21.8
1 month 16.52
Extreme 16.52
21.82
Current year 16.46
Extreme 16.46
30.3
1 year 16.46
Extreme 16.46
32.48
3 years 3.06
Extreme 3.06
34.2
5 years 1.11
Extreme 1.11
34.2
10 years 1.11
Extreme 1.11
34.2
Manager TitleAgeSince
Chief Executive Officer 56 12/10/2023
Chief Executive Officer 60 04/12/2017
Director of Finance/CFO - 17/02/2023
Director TitleAgeSince
Chairman 69 14/06/2018
Director/Board Member 60 14/06/2018
Director/Board Member 57 14/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
26/05/26 Sell -7,225 0.0184%
13/12/25 Sell 30,000 0.0766%
08/12/25 Sell 30,000 0.0766%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-2.39%-28.28%+559.26% 977M
+0.01%+8.40%+58.48%+69.01% 68.22B
+1.22%+10.23%+18.35%+87.67% 59.82B
+0.24%+1.97%+24.62%+94.87% 56.07B
+1.60%+17.36%+32.51%+123.69% 47.67B
-1.32%+6.47%+30.74%+43.37% 45.95B
-3.54%+2.60%+216.44%+864.34% 43.29B
-3.33%+5.73%+23.28%+47.32% 35.66B
-2.19%-3.16%+93.83%+63.14% 34.73B
+2.92%+9.31%-37.01%+410.20% 25.47B
Average -0.72%+4.85%+43.30%+236.29% 42B
Weighted average by Cap. -0.42%+5.39%+52.45%+180.57%

Financials

2026 *2027 *
Net sales 170M 206M 184M 154M 292M 19.27B 300M 2.03B 810M 10.32B 771M 755M 32.64B 220M 266M 239M 200M 378M 24.94B 388M 2.63B 1.05B 13.36B 998M 977M 42.24B
Net income 9.2M 11.13M 9.98M 8.35M 15.8M 1.04B 16.25M 110M 43.87M 559M 41.75M 40.87M 1.77B 20.24M 24.49M 21.96M 18.38M 34.79M 2.3B 35.76M 242M 96.57M 1.23B 91.91M 89.96M 3.89B
Net Debt -6.24M -7.55M -6.77M -5.67M -10.72M -708M -11.02M -74.71M -29.77M -379M -28.33M -27.73M -1.2B -23.38M -28.29M -25.37M -21.24M -40.19M -2.65B -41.31M -280M -112M -1.42B -106M -104M -4.49B
Projected Income Statement - Annual - Kuros Biosciences AG
Logo Kuros Biosciences AG
Kuros Biosciences AG is a Switzerland‑based biotechnology company engaged in the research, development, and commercialization of biologic technologies for musculoskeletal care, with a focus on those supporting bone regeneration and bone growth. The Company's key product is MagnetOs, which is a synthetic bone graft technology available in multiple formats such as granules or putty. MagnetOs is designed to stimulate bone formation, including through mechanisms that engage the body’s immune response. The technology behind MagnetOs is associated with osteoimmunology, which involves immune‑modulated bone healing. MagnetOs uses the proprietary NeedleGrip submicron surface technology, which supports bone growth by enhancing biological responses related to healing. It is indicated for use across the skeletal system and is positioned as a bone graft option for procedures involving various anatomical regions.
Employees
213
Date Price Change Volume
10/11/26 CHF 19.58 -2.78% 112,090
09/11/26 CHF 20.14 +3.07% 121,208
06/11/26 CHF 19.54 -5.33% 257,132
05/11/26 CHF 20.64 -0.67% 289,922
04/11/26 CHF 20.78 +2.57% 185,467
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Kuros Biosciences AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
19.58CHF
Average target price
34.33CHF
Spread / Average Target
+75.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Kuros Biosciences AG
  1. Stock Market
  2. Stocks
  3. KURN Stock